Escitalopram in Patients With Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of escitalopram after 8 weeks of
treatment in patients with Generalized Anxiety Disorder (GAD), to evaluate proportion of
patients who respond to escitalopram during the treatment period, and to evaluate safety of
escitalopram.